Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, Cholecystectomy & appendectomy, Debridement & negative-pressure wound therapy, Lumbar fusion, Bariatric surgery, Antireflux & hiatal hernia surgery, Colorectal resection.
All companies · Product and company coverage
In 2025, Deroyal Industries reported engagement with 37 surgeons and other clinicians in the states MedaRep covers, worth $4,083 in consulting, speaking, meals and travel for its device products, the most in Tennessee ($2,047 to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Tennessee ($2,047, 2 engaged), South Carolina ($675, 1 engaged), Texas ($279, 12 engaged), Pennsylvania ($256, 3 engaged), Missouri ($213, 2 engaged).
In the last ten years FDA made 4 decisions for Deroyal Industries (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 7 procedure families, the most in 2025 (1). The latest was on 2025-11-21.
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-11-21 | 510(k) | K250586 | Prospera Spectruum Negative Pressure Wound Therapy Black Foam Kits and White Foam Accessory |
| 2024-04-18 | 510(k) | K230233 | Prospera Spectruum Negative Pressure Wound Therapy System |
| 2018-04-04 | 510(k) | K173072 | Algidex Ag Silver Alginate Wound Dressing |
| 2017-08-17 | 510(k) | K171475 | DeRoyal Laprador Specimen Retrieval System |
| 2015-07-23 | 510(k) |
| K142962 |
| PROTOCOL Incision Dressing |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Deroyal Industries.